Login to Your Account

Novartis' Ilaris Gets Thumbs Down as Gout Treatment

By Mari Serebrov

Wednesday, June 22, 2011
Novartis AG may have proven the efficacy of its Ilaris to treat gouty arthritis attacks, but it couldn't overcome the safety concerns.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription